This product, although approved, is not yet available to purchase via
TheSocialMedwork. However, if you are interested in staying informed
please leave your email address, and we will update you as soon as we
are able to source it and offer it for purchase.
|| Valeant Pharmaceuticals
|| Open-angle glaucoma, Ocular hypertension
| Mode of Action
|| Prostaglandin analog
| Approval Status
|| FDA approved (USA)
Other medicines for glaucoma
If you are interested in other medicines for glaucoma, please visit our glaucoma
What is latanoprostene bunod ophthalmic solution?
Vyzulta (latanoprostene bunod ophthalmic solution) is a prostaglandin analog 
approved by the FDA on November 2, 2017 
, for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension 
is an eye disease characterized by the loss of vision or even blindness
due to damage to the optic (eye) nerve; the damage is often associated
with elevated pressure in the eye 
. Glaucoma is the leading cause of irreversible blindness in the world 
Intraocular pressure is a major modifiable risk factor for glaucoma progression 
Vyzulta (latanoprostene bunod ophthalmic solution) is the first
prostaglandin analog which can provide consistent and sustained lowering
of intraocular pressure 
It is thought to lower intraocular pressure by increasing outflow of
aqueous humor from the eye and in this way it reduces risk of
glaucomatous visual field loss 
When will latanoprostene bunod ophthalmic solution be available?
Vyzulta (latanoprostene bunod ophthalmic solution) was approved by the FDA on November 2, 2017 
We have already contacted our sourcing partners and we will offer this
product on our website as soon as we are able to source it for our
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Medicine information contained herein may be time sensitive. The absence of a warning for a given medicine or combination thereof in no way should be construed to indicate that the medicine or combination is safe, effective or appropriate for any given patient. Always consult your treating physician before starting a course of treatment.